Controversy continues to surround the biological activity of short fibre chryso tile largely due to a lack of 'pure exposure' situations available for study: most human exposures are confounded by concomitant long fibre and/or amphi bole exposure. This report presents the morphological and morphometric findings of a lifetime inhalation study of F344 rats exposed to three types of chrysotile. Fibres from the first sample, from Coalinga, Calif., are almost all less than 5 μm in length and do not contain amphibole types of asbestos. The other two, from Quebec, Canada, are a sample from the Jeffrey mine and the UICC/B standard. These are both long fibre preparations with a minor degree of amphibole contamination. Animals exposed to these fibres displayed no tumours above control levels following exposure to Coalinga chrysotile but gave significant tumourigenic responses with both types of Canadian fibres.
Stanton M., Wrench F.: Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst1972;48:797-821.
2.
Stanton M., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A.: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst1981 ;67:965-975.
3.
Pott F.: Asbestos use and carcinogeneity in Germany and a comparison with animal studies . Ann Occup Hyg1994;38:589-600.
4.
Mossman B., Bignon J., Corn M., Seaton A., Gee Jbl: Asbestos: Scientific developments and implications for public policy. Science1990; 24:294-301.
5.
Davis J.: Mineral fibre carcinogenesis: Experimental data relating to the importance of fibre type, size, deposition, dissolution and migration; in Bignon J, Peto J, and Sarracci R (eds): Non-Occupational Exposure to Mineral Fibres. Lyon, International Agency for Research on Cancer, 1989, vol. 90 pp 33-43.
6.
Davis JM, Jones A.: Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br JExp Pathol1988 ;69:717-737.
7.
Gardner L.: Asbestosis; in Lanza AO (ed): Silicosis and Asbestosis. London, Oxford University Press, 1938, p 257.
8.
Gardner LU: Response to inhaled asbestos fibres. Third Symposium on Silicosis, Saranac Lake, June 1937, pp 93-95.
9.
Gardner L., Cummings DE: Studies in experimental pneumoconiosis. J Ind Hyg1931;13: 97.
10.
Vorwald AJ, Durkan TM, Pratt PC: Experimental studies of asbestosis. AMA Arch Ind HygOccup Med1951;3:1-43.
11.
Gross P., de Treville L.: The pulmonary response to Coalinga asbestos dust: A preliminary investigation (final report) (produced for the JM Company). Ind Hyg Found Am1968:10-23.
12.
Platek S., Groth D., Ulrich C., Stettler L., Finnell M., Stoll M.: Chronic inhalation of short asbestos fibres. Fund Appl Toxicol1985 ;5:327-340.
13.
Langer AM, Wolff MS, Rohl A., Selikoff I.: Variation of properties of chrysotile asbestos subjected to milling. J Tox EnvironHealth1978;4: 173-188.
14.
Davis J., Addison J., Bolton R., Donaldson K., Jones A.: The pathogenicity of long vs short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br JExp Pathol1986;67:415-430.
15.
Berman W., Crump K., Chatfield E., Davis J., Jones A.: The sizes, shapes and mineralogy of asbestos structures that induce lung tumors or mesotheliomas in AF/HAN rats following inhalation. Risk Analysis1995;15:181-195.
16.
Ilgren E., Chatfield E.: Coalinga fibre - A short, amphibole-free chrysotile. Evidence for lack of fibrogenic activity. Indoor Built Environ1997;6:264-276.
17.
McConnell EE , Wagner JC, Skidmore JW, Moore JA: A comparative study of the fibrogenic and carcinogenic effects of UICC Canadian chrysotile B asbestos and glass microfibre (JM 100). Biological Effects of Man-Made Mineral Fibres, Report on a WHO/IARC Meeting, Copenhagen, April 1982, annex 45, pp 234-242.
18.
Wagner JC, Berry GB, Hill RJ, Munday DE, Skidmore JW: Animal experiments with MMM(V)F - Effects of inhalation and intra-pleural inoculation in rats. Biological Effects of Man-Made Mineral Fibres, Report on a WHO/ IARC Meeting, Copenhagen, April 1982, annex 42, pp 210-235.
19.
Pinkerton K.: Lung reaction to chronic inhalation of three types of chrysotile asbestos during the lifespan of theFischer344 rat; PhD thesis, Duke University , Durham, 1982.
20.
NTP: Inventory accession documents 1995.
21.
Pinkerton K. , Barry B., O'Neil J., Raub J., Pratt P., Crapo J.: Morphologic changes in the lung during the lifespan of Fischer 344 rats. Am J Anat1982 ;164:155-174.
22.
Pinkerton K. , Pratt C., Brody AR, Crapo J.: Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Am J Pathol1984 ; 117:484-498.
23.
Pinkerton K. , Young S., Fram E., Crapo J.: Alveolar type II cell responses to chronic inhalation of chrysotile asbestos in rats. Am J Respir Cell Mol Biol1990;3:543-552.
24.
Muhle H., Pott F., Bellman B., Takenaka S., Ziem U.: Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg1987 ;31:755-764.
25.
EPA Region IX related scientific advisory board [SAB]: Correspondence from Dr. Gary Friedman, Kaiser Medical Group to Daniel Aldrich , Department of Social Ecology, University of California , Irvine November 17, 1989.
26.
Elmes P.: Conflicts in evidence on the health effects of mineral fibres. in: Liddell D, Miller K (eds): Mineral Fibres in Health and Disease. Boca Raton, CRC Press, 1991, pp 321-337.
27.
Davis J., Beckett S., Bolton R., Collings P., Middleton A.: Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer1978;37:673-688.
28.
Wagner, J.: Biological effects of short fibres. Animal models- Pneumoconiosis I. Proc VIIth Int Pneumoconiosis Conf, NIOSH- ILO, Pittsburgh, August 1988.
29.
Oberdorster G. : Evaluation and use of animal models to assess mechanisms of fibre carcinogenicity; in Mossmun B, Bignon J (eds): Mechanisms of Fibre Carcinogenesis. IARC Scientific Publications, Lyon, 1996, vol 140, pp 107-127.
30.
Morgan A.: Acid leaching studies of chrysotile asbestos from mines in the Coalinga region of California and from Quebec and British ColumbiaAnn Occup Hyg1997;41:249-268.
31.
Pott F., Ziem U., Reiffer F., Huth F., Ernst H., Mohr U.: Carcinogenicity studies in fibres, metal compounds, and some other dusts in rats. Exp Pathol1987;32:129-152.
32.
Rittinghausen S., Ernst H., Muhle H., Fuhst R., Mohr U.: Histopathological analysis of tumour types after intraperitoneal injection of mineral fibres in rats; in Brown RC, Hoskins JA, Johnson NF (eds): Mechanisms in Fibre Carcinogenesis. NATO ASI Series, Albuquerque, June, 1991 , pp 81-89.
33.
Davis Jmg: Biological effects of mineral dust samples. 5th Int Colloquium on Dust Measuring Technique and Strategy, Asbestos Int Assoc Johannesburg, 1984:1-35.
34.
Bolton R., Davis J., Miller B., Donaldson K., Wright A.: The effects of dose of asbestos on mesothelioma production in the laboratory rat. 6th Pneumoconiosis Conf, Bockum, 1983, pp 1029-1035.
35.
Davis Jmg: Lack of experimental evidence for the occurrence of tissue damage and disease following exposure to low doses of asbestos. Minisymp 'Effects of Low Dasages of Asbestos Exposure', Sydney, 1988.
36.
Ilgren E.: Mesothelioma threshold; in Mossman B, Begin R (eds): Effects of Mineral Dusts on Cells. NATO ASI Series. Berlin, Springer, 1989, pp 454-464.
37.
Ilgren, E.: Mesotheliomas of Animals: A Comprehensive, Tabular Compendium of the World's Literature. Boca Rato, CRC Press, 1993 , pp 356.
38.
Oberdorster G.: Macrophage-associated responses to chrysotile . Ann Occup Hyg1994;38: 601-615.
39.
Maltoni C., Minardi F., Morisi L.: The relevance of the experimental approach in the assessment of the oncogenic risks from fibrous and non-fibrous particles: The ongoing project of the Bologna Institute of Oncology. Med Lav1982; 4:394-407.
40.
Maltoni C., Minardi F.: Recent results of carcinogenicity bioassays of fibres and other particulate materials; in Bignon J, Peto J, Saracci R (eds): Non-Occupational Exposure to Mineral Fibres. Lyon, IARC Scientific Publications1989; 90, pp 46-53.
41.
Davis J., Addison J., Bolton R., Donaldson K., Jones A.: Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Br JExp Pathol1986;67:113-129.
42.
Suzuki Y.: Carcinogenic and fibrogenic effects of zeolites: Preliminary observations . Environ Res1982;27:433-445.
43.
Suzuki Y., Kohyama N.: Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. Environ Res1984;35: 277-292.
44.
Rittinghausen S., Ernst H., Muhle H., Mohr U.: Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp Tox Pathol1992 ;44:55-58.
45.
Wagner JC: The effects of the inhalation of asbestos in rats. Br J Cancer1974;29: 252-269.
46.
Wagner JC, Berry G., Skidmore JW, Pooley FD: The comparative effects of three chrysotiles by injection and inhalation in rats; in Wagner (ed): Biological Effects of Mineral Fibres. Lyon, IARC Scientific Publications, 1980, pp 363-372.
47.
McConnell E., Adkins B.: Studies on the chronic toxicity (inhalation) of wollastonite in Fischer 344 rats. Inhalation Toxicol1991;3:323-337.
48.
Davis J., Jones A., Miller B.: Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide or quartz. Br JExp Pathol1991;72:501-525.
49.
Davis JM: The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats. Br JExp Pathol1980 ;61:272-279.
Davies P., de Mello D., Reid L.: Structural methods in the study of development of the lung; in Gil J (ed): Models of Lung Disease. New York, Dekker, 1990, vol 47, pp 409-472.
52.
Berenblum I.: Carcinogenesis, a biological problem ; in Neuberger A, Tatum E (eds): Frontiers of Biology. New York, Elsevier, 1974, vol 4.
53.
Davis J., Conian H.: The relationship between fibrosis and cancer in experimental animals exposed to asbestos and other factors. Environ Health Perspect1990;88:305-309.
54.
Davis JM: Mixed fibrous and non-fibrous dust exposures and interactions between agents in fibre carcinogenesis; in Kane AB, Boffetta P, Saracci R, Wilbourn JD (eds): Mechanisms of Fibre Carcinogenesis . Lyon, IARC Scientific Publications , 1996, vol 140, pp 127-133.
55.
Lehnert B., Sebring R., Oberdorster G.: Pulmonary Macrophages: Phenomena associated with the 'particle overload' condition ; in Dung-worth E, Maudersley J, Oberdorster G (eds): Toxic and Carcinogenic Effects of Solid Particles in the Respiratory Tract. ILSI Monograph. WashingtonILSI Press, 10, pp 159-174.
56.
Ilgren E., Chatfield E.: Coalinga fibre - A short, amphibole-free chrysotile. Lack of Biopersistence. Indoor Built Environ, 1998;7:98-109.
57.
Addison J., Davies D.: Analysis of amphibole asbestos in chrysotile and other minerals. Ann Occup Hyg1990;34:159-175.
58.
Wagner J., Griffiths M., Munday D.: Recent investigations in animals and humans; in Wagner J, Pooley F (eds): Biological Effects of Chrysotile. Accomplishments in Oncology, Philadelphia, Lippincott, 1986, vol 1, pp 111-120.
59.
Sluis-Cremer G.: Linking chrysotile asbestos with mesothelioma (letter to the editor). Am J Ind Med1955;14:631.
60.
Rees D., du Toit R., Rendall R., van Sittert G., Rama D.: Tremolite in southern African chrysotile. South Afr J Sci1992;88:468-469.
61.
Pooley F.: Investigation of the Importance of Tremolite in the Production of Asbestos-Related Disease and Its Relevance as a Long-Term Indicator of Chrysotile Exposure . LondonHSE1990, pp 122.
62.
Davis J.: The biological effects of mineral fibres. Br Occup Hyg1981 ;24:227-234.
63.
Sebastien P. , McDonald J., McDonald A., Case B., Harley R.: Respiratory cancer in chrysotile textile and mining industries: Exposure inferences from lung analyses. Br J Ind Med1989; 46:180-187.
64.
Nicholson W. , Landrigan P.: The carcinogenicity of chrysotile asbestos . Adv Mod Environ Toxicol1994;xxii:407-423.
65.
Stayner L., Dankovic D., Lemen R.: Occupational exposure to chrysotile asbestos and cancer risk: A review of the amphibole hypothesis. Am J Public Health1996:86;179-186.
66.
Smith A., Wright C.: Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med1996;30:252-266.
67.
Mossman B., Gee B.: The amphibole hypothesis of asbestos-related mesothelioma - Still supported by scientists and scientific data. Am J Public Health, 1997, in press.
68.
McDonald J. , McDonald A.: Epidemiology of mesothelioma from estimated incidence. Prev Med1977;6:426-446.
69.
McDonald A., McDonald J.: Epidemiology of malignant mesothelioma; in Antman K, Aisner J (eds): Asbestos-Related Malignancy. Orlando, Grune & Stratton, 1987, chapt 2, pp 190-212.
70.
McDonald J., McDonald A.: Epidemiology of mesothelioma; in Liddell D , Miller K (eds): Mineral Fibres in Health and Disease. Boca Raton, CRC Press, 1991, chapt 12, pp 147-169.
71.
McDonald J. , McDonald A.: The epidemiology of mesothelioma in historical context. Eur Respir J1996;9:1932-1942.
